John Higgins
Board Member
OmniAb, Inc. (OABI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
2007-01-01–2022-12-31
-
Start not stated–2022-12-05
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Ligand Pharmaceuticals Inc (LGND) | Former Chief Executive Officer | $675,264 | $16,764,990 |
| 2021 | Ligand Pharmaceuticals Inc (LGND) | Former Chief Executive Officer | $696,583 | $9,587,211 |
| 2020 | Ligand Pharmaceuticals Inc (LGND) | Former Chief Executive Officer | $668,333 | $5,842,767 |
| 2019 | Ligand Pharmaceuticals Inc (LGND) | Chief Executive Officer | $648,192 | $6,770,376 |
| 2018 | Ligand Pharmaceuticals Inc (LGND) | Chief Executive Officer | $627,413 | $6,306,803 |
| 2017 | Ligand Pharmaceuticals Inc (LGND) | Chief Executive Officer | $611,656 | $5,513,207 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.